Prion Deactivation Technologies - Global Value Market

Prion Deactivation Technologies - Global Value Market
The Prion related products include BSE detection test Kits, Deactivation/Inactivation technologies, Reagents and Services. The study includes estimations and predictions for the global BSE Post Mortem Testing Market. The market is also analyzed by geographic regions encompassing North America, Europe, Japan and Rest of World. Business profiles of 25 major companies are discussed in the report. The report serves as a complete guide to global Prion Detection, Reduction and Inactivation Market covering more than 120 companies that are engaged in research for development of antemortem BSE and CJD test kits, development and supply of BSE Test kits and development of prion Reduction Filters. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. http://bharatbook.com/market-research-reports/biotechnology-market-research-report/prions.html

Report Highlights

This report may help strategists, investors, laboratories, contract research organizations, biotechnology & Healthcare companies, academic professionals, drug approval authorities, and other organizations to –

* Identify Market Opportunities
* Review and Analyze Global and Regional Markets
* Gauge Market Potential for your Products
* Identify Competition
* Use Market Research for exploring new areas
* Acquire Meaningful Guidelines for Strategic Planning
* Gear up for Market Entry
* Get Actionable Information

Market Research

Analytics and data presented in each report pertain to several parameters such as –

* Global and Regional Market Sizes, Market Shares, Market Trends
* Product (Global and Regional) Market Sizes, Market Shares, Market Trends
* Technology Trends
* Corporate Intelligence
* Key Companies By Sales, Brands, Products
* Other Strategic Business Affecting Data

Key Report Findings

Prions are considered unique as they replicate without the presence of nucleic acids. These are observed to replicate by modifying neighboring prions to conform to the required shape. After the completion of the protein reconfirmation the modified or mutated prion becomes infective. The reason that prions are gaining importance is because they cause certain neurodegenerative diseases in animals and humans, which are incurable as of date. Creutzfeldt-Jakob disease in humans and Bovine spongiform encephalopathy (mad cow disease) are two such examples. The infected person or animal dies within months or even weeks after the symptoms start surfacing.

Scientists across the world are anxiously waiting to unearth a link between the disease scrapie, which is commonly found in the goats and sheep with that of other diseases like bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD). This is expected to bring about a revolution in the field of both agriculture and pharmaceutical developments. The very information pertaining to this research created a widespread impact on the pharmaceutical industries and its development can be witnessed in proportion. The disease is caused by mutated prions, and is not similar to other diseases that affect human beings and domestic animals. The main responsibility to control this disease is vested with the pharmaceutical industry and it is influenced in several ways.

European Union has imposed very stringent measures for controlling TSE infections in domestic animals. Slaughterhouses in EU are required to test for BSE even the healthy cattle that are 30 years or more of age. From the cattle that die on the farm, those that are 24 months or more of age have to be tested for BSE. Out of the cattle being sent for rendering, those that are 24 months and above of age, are to be tested for presence of BSE infection before rendering. Apart from these, any cattle, which displays any physical symptom of BSE, has to be tested, irrespective of the age thus increasing the market for BSE testing in Europe. Only 10% of cows are tested for BSE in the US. The new US policy is a sharp contrast to the measures taken by countries such as Japan, where 100 percent of cows are tested for BSE infection at the time of slaughtering, to ensure that the meat is safe for human consumption. Japan insists that all the cattle be tested at the time of slaughter.